Prétet Jean-Luc, Dalstein Véronique, Monnier-Benoit Sylvain, Delpeut Sébastien, Mougin Christiane
Laboratoire de Biologie Cellulaire et Moléculaire, EA3181 et IFR 133, Centre Hospitalier Universitaire J. Minjoz, Boulevard A. Fleming, 25030 Besançon Cedex, France.
J Clin Virol. 2004 Oct;31(2):140-7. doi: 10.1016/j.jcv.2004.02.008.
High risk human papillomavirus (HR-HPV) load determined by quantitative methods has already been considered as highly predictive of future development of high grade cervical lesions. Some studies also demonstrated that Hybrid Capture II (HCII) results can be considered as a reflection of HPV DNA load, while others did not. HCI assay, well suited for routine HR-HPV screening, is not especially dedicated for quantitative use. However, we have recently shown that women with high viral loads assessed by HCII were at increased risk of cervical precancer.
The aim of the study was to determine if the values given by the HCII assay can be considered as quantitative.
We used a real-time PCR allowing precise quantification of both HPV16 genome and albumin gene to normalize the measuring HPV16 load in cervical cells and to compare the data with those obtained by HCIIin a series of 40 HR-HPV positive samples.
Reproducibility of the HPV16 real-time PCR, assessed from nine independent experiments of serial dilutions of SiHa cell DNA, was reflected in coefficients of variation for standard curves of crossing point (Cp) values below 5%. The HPV16 loads with a broad individual variability were significantly related to the cumulative load estimated by HCII and did not depend on the cellularity of samples.
We assume that the HCII values can be used as a quantitative measure of HR-HPV DNA, so long as cervical specimens are collected using standardized protocols.
通过定量方法测定的高危型人乳头瘤病毒(HR-HPV)载量已被认为是高级别宫颈病变未来发展的高度预测指标。一些研究还表明,杂交捕获二代(HCII)检测结果可被视为HPV DNA载量的反映,而其他研究则不然。HCI检测非常适合常规HR-HPV筛查,但并非专门用于定量检测。然而,我们最近发现,经HCII评估病毒载量高的女性患宫颈上皮内瘤变的风险增加。
本研究的目的是确定HCII检测给出的值是否可被视为定量值。
我们使用了一种实时PCR技术,能够精确量化HPV16基因组和白蛋白基因,以标准化宫颈细胞中HPV16载量的测量,并将数据与通过HCII在一系列40个HR-HPV阳性样本中获得的数据进行比较。
从SiHa细胞DNA系列稀释的9个独立实验评估的HPV16实时PCR的重复性,反映在交叉点(Cp)值标准曲线的变异系数低于5%。具有广泛个体差异的HPV16载量与HCII估计的累积载量显著相关,且不依赖于样本的细胞数量。
我们认为,只要使用标准化方案收集宫颈标本,HCII值可作为HR-HPV DNA的定量指标。